Clinical cases identification tumors of the pancreas in patients of chronic lymphocytic leukemia

Author(s):  N.V. Kurkina, National Research Ogarev Mordovia State University, Saransk, Russia, Republican Clinical Hospital № 4,

E.I. Gorshenina, National Research Ogarev Mordovia State University, Saransk, Russia,

L.V. Chegodaeva, National Research Ogarev Mordovia State University, Saransk, Russia,

Issue:  Volume 40, №26

Rubric:  Clinical Medicine

Annotation:  Malignant neoplasms of lymphatic and hematopoietic tissue (gemoblastozy) are among the most common tumours and are one of the most urgent medical and social problems of modern Oncogematology. According to the who cancer took second place among all causes of mortality in the world. Chronic lymphatic leukemia (CLL) taped primarily in patients over the age of 60 years. Most often there is slowly progressive course of the disease, in which a justified tactic expectant patients before the advent of the indications for therapy. Other patients have noted a progressive course CLL requiring early treatment. The goal of treatment of this disease is determined by the age of the patient and komorbidnost'ju. In patients with good somatic status without Comorbidities should strive to achieve complete remission, which leads to an increase in life expectancy. Elderly patients the aim of treatment is to control the disease with low toxicity therapy. In patients aged patients with signs of organ failure takes place palliative therapy. Against the backdrop of leukemia often identifies the second solid tumors, which significantly affect the further tactics and treatment of patients. Against the backdrop of lymphoproliferative leukemia development second malignant tumors faster, with the earlier appearance of metastases. Prior to application of cytostatic therapy is regarded as one of the risk factors for developing a second tumor. Presents clinical cases patients with chronic lymphocytic leukemia who had diagnosed a malignant tumor of the pancreas with metastatic lesions of the liver. At a certain stage of development of the disease malignant tumor becomes the leading. The second tumor burden for leukemia, affect further treatment tactics and significantly worsen the quality of life of patients

Keywords:  chronic lymphocytic leukemia, remission, relapse, chemotherapy, the tumor of the pancreas, metastases

Full text (PDF):  Download

Downloads count:  637